Pular para o conteúdo
Merck

Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage.

Skeletal muscle (2018-08-04)
Yosuke Hiramuki, Stephen J Tapscott
RESUMO

SMCHD1 is a disease modifier and a causative gene for facioscapulohumeral muscular dystrophy (FSHD) type 1 and type 2, respectively. A large variety of different mutations in SMCHD1 have been identified as causing FSHD2. In many cases, it is unclear how these mutations disrupt the normal function of SMCHD1. We made and analyzed lenti-viral vectors that express Flag-tagged full-length or different mutant SMCHD1 proteins to better understand the functional domains of SMCHD1 in muscle cells. We identified regions necessary for nuclear localization, dimerization, and cleavage sites. Moreover, we confirmed that some mutants increased DUX4 expression in FSHD1 myoblasts. These findings provide an additional basis for understanding the molecular consequences of SMCHD1 mutations.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
ANTI-FLAG® M2 monoclonal, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Sigma-Aldrich
Anti-α-tubulina monoclonal, clone DM1A, ascites fluid
Sigma-Aldrich
Anti-SMCHD1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution